Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea.
Pharmacoecon Open
; 7(2): 189-197, 2023 Mar.
Article
en En
| MEDLINE
| ID: mdl-36171465
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Health_economic_evaluation
/
Incidence_studies
/
Risk_factors_studies
Idioma:
En
Año:
2023
Tipo del documento:
Article